Sivik Global Healthcare LLC Puma Biotechnology, Inc. Transaction History

Sivik Global Healthcare LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$12.3 - $35.76 $492,000 - $1.43 Million	-40,000 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$20.77 - $42.37 $830,800 - $1.69 Million	40,000 New	40,000 $1.55 Million
Q3 2018 Nov 13, 2018	SELL	$41.2 - $59.85 $824,000 - $1.2 Million	-20,000 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$48.3 - $68.25 $241,500 - $341,250	-5,000 Reduced 20.0%	20,000 $1.18 Million
Q1 2018 May 08, 2018	SELL	$59.7 - $99.25 $597,000 - $992,500	-10,000 Reduced 28.57%	25,000 $1.7 Million
Q4 2017 Feb 08, 2018	BUY	$93.85 - $132.45 $1.41 Million - $1.99 Million	15,000 Added 75.0%	35,000 $3.46 Million
Q3 2017 Nov 08, 2017	BUY	$72.0 - $119.75 $1.44 Million - $2.4 Million	20,000	20,000 $2.4 Million

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.